Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study.

De Pablo-Fernandez E, Goldacre R, Pakpoor J, Noyce AJ, Warner TT.

Neurology. 2018 Jul 10;91(2):e139-e142. doi: 10.1212/WNL.0000000000005771. Epub 2018 Jun 13.

PMID:
29898968
2.

Sensitivity and Specificity of the ECAS in Parkinson's Disease and Progressive Supranuclear Palsy.

Foley JA, Niven EH, Paget A, Bhatia KP, Farmer SF, Jarman PR, Limousin P, Warner TT, Morris HR, Bak TH, Abrahams S, Cipolotti L.

Parkinsons Dis. 2018 May 9;2018:2426012. doi: 10.1155/2018/2426012. eCollection 2018.

3.

Autonomic dysfunction in Parkinson's disease: The hidden game changer?

De Pablo-Fernandez E, Warner TT.

Mov Disord. 2018 May 14. doi: 10.1002/mds.27422. [Epub ahead of print] No abstract available.

PMID:
29756259
4.

A Histologic Study of the Circadian System in Parkinson Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy.

De Pablo-Fernández E, Courtney R, Warner TT, Holton JL.

JAMA Neurol. 2018 Apr 30. doi: 10.1001/jamaneurol.2018.0640. [Epub ahead of print]

PMID:
29710120
5.

Phenotypes, genotypes, and the management of paroxysmal movement disorders.

Silveira-Moriyama L, Kovac S, Kurian MA, Houlden H, Lees AJ, Walker MC, Roze E, Paciorkowski AR, Mink JW, Warner TT.

Dev Med Child Neurol. 2018 Jun;60(6):559-565. doi: 10.1111/dmcn.13744. Epub 2018 Mar 30. Review.

PMID:
29600549
6.

No evidence of iatrogenic human transmission in autopsy confirmed multiple system atrophy.

De Pablo-Fernandez E, Cerdán Santacruz D, Warner TT, Holton JL.

Mov Disord. 2018 Mar 23. doi: 10.1002/mds.27370. [Epub ahead of print] No abstract available.

PMID:
29570847
7.

Dopamine reuptake transporter-single-photon emission computed tomography and transcranial sonography as imaging markers of prediagnostic Parkinson's disease.

Noyce AJ, Dickson J, Rees RN, Bestwick JP, Isaias IU, Politis M, Giovannoni G, Warner TT, Lees AJ, Schrag A.

Mov Disord. 2018 Mar;33(3):478-482. doi: 10.1002/mds.27282. Epub 2018 Jan 30.

PMID:
29380907
8.

Compulsive sexual behaviour in Parkinson's disease is associated with higher doses of levodopa.

Barbosa PM, Grippe T, Lees AJ, O'Sullivan S, Djamshidian A, Warner TT.

J Neurol Neurosurg Psychiatry. 2017 Nov 24. pii: jnnp-2017-317298. doi: 10.1136/jnnp-2017-317298. [Epub ahead of print] No abstract available.

PMID:
29175897
9.

The neuropsychological profile of Othello syndrome in Parkinson's disease.

Foley JA, Warner TT, Cipolotti L.

Cortex. 2017 Nov;96:158-160. doi: 10.1016/j.cortex.2017.08.009. Epub 2017 Aug 16. No abstract available.

PMID:
28917380
10.

Dystonia.

De Pablo-Fernandez E, Warner TT.

Br Med Bull. 2017 Sep 1;123(1):91-102. doi: 10.1093/bmb/ldx019. Review.

PMID:
28910989
11.

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial.

Athauda D, Maclagan K, Skene SS, Bajwa-Joseph M, Letchford D, Chowdhury K, Hibbert S, Budnik N, Zampedri L, Dickson J, Li Y, Aviles-Olmos I, Warner TT, Limousin P, Lees AJ, Greig NH, Tebbs S, Foltynie T.

Lancet. 2017 Oct 7;390(10103):1664-1675. doi: 10.1016/S0140-6736(17)31585-4. Epub 2017 Aug 3.

PMID:
28781108
12.

Iatrogenic B12-deficient peripheral neuropathy following nitrous oxide administration for functional tonic leg spasm: A case report.

Kaski D, Kumar P, Murphy E, Warner TT.

Clin Neurol Neurosurg. 2017 Sep;160:108-110. doi: 10.1016/j.clineuro.2017.07.006. Epub 2017 Jul 6. No abstract available.

PMID:
28709008
13.

Association of Autonomic Dysfunction With Disease Progression and Survival in Parkinson Disease.

De Pablo-Fernandez E, Tur C, Revesz T, Lees AJ, Holton JL, Warner TT.

JAMA Neurol. 2017 Aug 1;74(8):970-976. doi: 10.1001/jamaneurol.2017.1125.

PMID:
28655059
14.

Nomenclature of genetic movement disorders: Recommendations of the International Parkinson and Movement Disorder Society task force.

Marras C, Lang A, van de Warrenburg BP, Sue CM, Tabrizi SJ, Bertram L, Mercimek-Mahmutoglu S, Ebrahimi-Fakhari D, Warner TT, Durr A, Assmann B, Lohmann K, Kostic V, Klein C.

Mov Disord. 2017 May;32(5):724-725. doi: 10.1002/mds.27045. No abstract available.

PMID:
28513081
15.

Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomics.

Magdalinou NK, Noyce AJ, Pinto R, Lindstrom E, Holmén-Larsson J, Holtta M, Blennow K, Morris HR, Skillbäck T, Warner TT, Lees AJ, Pike I, Ward M, Zetterberg H, Gobom J.

Parkinsonism Relat Disord. 2017 Apr;37:65-71. doi: 10.1016/j.parkreldis.2017.01.016. Epub 2017 Jan 31.

PMID:
28214264
16.

Hypothalamic α-synuclein and its relation to weight loss and autonomic symptoms in Parkinson's disease.

De Pablo-Fernandez E, Courtney R, Holton JL, Warner TT.

Mov Disord. 2017 Feb;32(2):296-298. doi: 10.1002/mds.26868. Epub 2016 Nov 28. No abstract available.

PMID:
27892607
17.

Neuroendocrine abnormalities in Parkinson's disease.

De Pablo-Fernández E, Breen DP, Bouloux PM, Barker RA, Foltynie T, Warner TT.

J Neurol Neurosurg Psychiatry. 2017 Feb;88(2):176-185. doi: 10.1136/jnnp-2016-314601. Epub 2016 Oct 31. Review.

PMID:
27799297
18.

Astrogliopathy predominates the earliest stage of corticobasal degeneration pathology.

Ling H, Kovacs GG, Vonsattel JP, Davey K, Mok KY, Hardy J, Morris HR, Warner TT, Holton JL, Revesz T.

Brain. 2016 Dec;139(Pt 12):3237-3252. Epub 2016 Oct 25.

PMID:
27797812
19.

Reply letter to Jinnah "Locus pocus" and Albanese "Complex dystonia is not a category in the new 2013 consensus classification": Necessary evolution, no magic!

Klein C, Lang A, van de Warrenburg BP, Sue CM, Tabrizi SJ, Bertram L, Mercimek-Mahmutoglu S, Ebrahimi-Fakhari D, Warner TT, Durr A, Assmann B, Kostic V, Lohmann K, Marras C; International Parkinson and Movement Disorder Society Task Force on Classification and Nomenclature of Genetic Movement Disorders.

Mov Disord. 2016 Nov;31(11):1760-1762. doi: 10.1002/mds.26763. Epub 2016 Sep 13. No abstract available.

PMID:
27619077
20.

MSA-C or SCA 17? A clinicopathological case update.

Doherty KM, De Pablo-Fernandez E, Houlden H, Polke JM, Lees AJ, Warner TT, Holton JL.

Mov Disord. 2016 Oct;31(10):1582-1584. doi: 10.1002/mds.26741. No abstract available.

PMID:
27477540
21.

Nomenclature of genetic movement disorders: Recommendations of the international Parkinson and movement disorder society task force.

Marras C, Lang A, van de Warrenburg BP, Sue CM, Tabrizi SJ, Bertram L, Mercimek-Mahmutoglu S, Ebrahimi-Fakhari D, Warner TT, Durr A, Assmann B, Lohmann K, Kostic V, Klein C.

Mov Disord. 2016 Apr;31(4):436-57. doi: 10.1002/mds.26527. Review.

PMID:
27079681
22.

Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data.

Mok KY, Sheerin U, Simón-Sánchez J, Salaka A, Chester L, Escott-Price V, Mantripragada K, Doherty KM, Noyce AJ, Mencacci NE, Lubbe SJ; International Parkinson's Disease Genomics Consortium (IPDGC), Williams-Gray CH, Barker RA, van Dijk KD, Berendse HW, Heutink P, Corvol JC, Cormier F, Lesage S, Brice A, Brockmann K, Schulte C, Gasser T, Foltynie T, Limousin P, Morrison KE, Clarke CE, Sawcer S, Warner TT, Lees AJ, Morris HR, Nalls MA, Singleton AB, Hardy J, Abramov AY, Plagnol V, Williams NM, Wood NW.

Lancet Neurol. 2016 May;15(6):585-96. doi: 10.1016/S1474-4422(16)00071-5. Epub 2016 Mar 24.

23.

Analysis of White Adipose Tissue Gene Expression Reveals CREB1 Pathway Altered in Huntington's Disease.

McCourt AC, Parker J, Silajdžić E, Haider S, Sethi H, Tabrizi SJ, Warner TT, Björkqvist M.

J Huntingtons Dis. 2015;4(4):371-82. doi: 10.3233/JHD-150172.

PMID:
26756592
24.

A Metabolic Study of Huntington's Disease.

Nambron R, Silajdžić E, Kalliolia E, Ottolenghi C, Hindmarsh P, Hill NR, Costelloe SJ, Martin NG, Positano V, Watt HC, Frost C, Björkqvist M, Warner TT.

PLoS One. 2016 Jan 8;11(1):e0146480. doi: 10.1371/journal.pone.0146480. eCollection 2016.

25.

Systematic review and meta-analysis of salivary protein concentration in Parkinson's disease.

Masters JM, Bestwick J, Warner TT, Giovannoni G, Proctor GB, Noyce AJ.

Mov Disord. 2015 Dec;30(14):1971-2. doi: 10.1002/mds.26462. Epub 2015 Nov 19. Review. No abstract available.

PMID:
26583568
26.

A large Indian family with rearrangement of chromosome 4p16 and 3p26.3 and divergent clinical presentations.

Iype T, Alakbarzade V, Iype M, Singh R, Sreekantan-Nair A, Chioza BA, Mohapatra TM, Baple EL, Patton MA, Warner TT, Proukakis C, Kulkarni A, Crosby AH.

BMC Med Genet. 2015 Nov 10;16:104. doi: 10.1186/s12881-015-0251-5.

27.

Erratum to: Strategies for treatment of dystonia.

Dressler D, Altenmueller E, Bhidayasiri R, Bohlega S, Chana P, Chung TM, Frucht S, Garcia-Ruiz PJ, Kaelin A, Kaji R, Kanovsky P, Laskawi R, Micheli F, Orlova O, Relja M, Rosales R, Slawek J, Timerbaeva S, Warner TT, Saberi FA.

J Neural Transm (Vienna). 2016 Mar;123(3):259. doi: 10.1007/s00702-015-1471-8. No abstract available.

PMID:
26546035
28.

A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington's Disease.

Kalliolia E, Silajdžić E, Nambron R, Costelloe SJ, Martin NG, Hill NR, Frost C, Watt HC, Hindmarsh P, Björkqvist M, Warner TT.

PLoS One. 2015 Oct 2;10(10):e0138848. doi: 10.1371/journal.pone.0138848. eCollection 2015.

29.

Strategies for treatment of dystonia.

Dressler D, Altenmueller E, Bhidayasiri R, Bohlega S, Chana P, Chung TM, Frucht S, Garcia-Ruiz PJ, Kaelin A, Kaji R, Kanovsky P, Laskawi R, Micheli F, Orlova O, Relja M, Rosales R, Slawek J, Timerbaeva S, Warner TT, Saberi FA.

J Neural Transm (Vienna). 2016 Mar;123(3):251-8. doi: 10.1007/s00702-015-1453-x. Epub 2015 Sep 14. Erratum in: J Neural Transm (Vienna). 2016 Mar;123(3):259.

PMID:
26370676
30.

Effects of age and cognition on a cross-cultural paediatric adaptation of the Sniffin' Sticks Identification Test.

Bastos LO, Guerreiro MM, Lees AJ, Warner TT, Silveira-Moriyama L.

PLoS One. 2015 Aug 12;10(8):e0131641. doi: 10.1371/journal.pone.0131641. eCollection 2015.

31.

Elevated salivary protein in Parkinson's disease and salivary DJ-1 as a potential marker of disease severity.

Masters JM, Noyce AJ, Warner TT, Giovannoni G, Proctor GB.

Parkinsonism Relat Disord. 2015 Oct;21(10):1251-5. doi: 10.1016/j.parkreldis.2015.07.021. Epub 2015 Jul 23.

PMID:
26231472
32.

Developmental regulation of tau splicing is disrupted in stem cell-derived neurons from frontotemporal dementia patients with the 10 + 16 splice-site mutation in MAPT.

Sposito T, Preza E, Mahoney CJ, Setó-Salvia N, Ryan NS, Morris HR, Arber C, Devine MJ, Houlden H, Warner TT, Bushell TJ, Zagnoni M, Kunath T, Livesey FJ, Fox NC, Rossor MN, Hardy J, Wray S.

Hum Mol Genet. 2015 Sep 15;24(18):5260-9. doi: 10.1093/hmg/ddv246. Epub 2015 Jul 1.

33.

A partially inactivating mutation in the sodium-dependent lysophosphatidylcholine transporter MFSD2A causes a non-lethal microcephaly syndrome.

Alakbarzade V, Hameed A, Quek DQ, Chioza BA, Baple EL, Cazenave-Gassiot A, Nguyen LN, Wenk MR, Ahmad AQ, Sreekantan-Nair A, Weedon MN, Rich P, Patton MA, Warner TT, Silver DL, Crosby AH.

Nat Genet. 2015 Jul;47(7):814-7. doi: 10.1038/ng.3313. Epub 2015 May 25.

PMID:
26005865
34.

A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes.

Magdalinou NK, Paterson RW, Schott JM, Fox NC, Mummery C, Blennow K, Bhatia K, Morris HR, Giunti P, Warner TT, de Silva R, Lees AJ, Zetterberg H.

J Neurol Neurosurg Psychiatry. 2015 Nov;86(11):1240-7. doi: 10.1136/jnnp-2014-309562. Epub 2015 Jan 14.

35.

Concomitant fragile X-associated tremor ataxia syndrome and Parkinson's disease: a clinicopathological report of two cases.

De Pablo-Fernandez E, Doherty KM, Holton JL, Revesz T, Djamshidian A, Limousin P, Bhatia KP, Warner TT, Lees AJ, Ling H.

J Neurol Neurosurg Psychiatry. 2015 Aug;86(8):934-6. doi: 10.1136/jnnp-2014-309460. Epub 2014 Dec 4. No abstract available.

36.

Perceptual decision-making in patients with Parkinson's disease.

Djamshidian A, O'Sullivan SS, Lawrence AD, Foltynie T, Aviles-Olmos I, Magdalinou N, Tomassini A, Warner TT, Lees AJ, Averbeck BB.

J Psychopharmacol. 2014 Dec;28(12):1149-54. doi: 10.1177/0269881114548437. Epub 2014 Sep 18.

PMID:
25237123
37.

SGCE and myoclonus dystonia: motor characteristics, diagnostic criteria and clinical predictors of genotype.

Peall KJ, Kurian MA, Wardle M, Waite AJ, Hedderly T, Lin JP, Smith M, Whone A, Pall H, White C, Lux A, Jardine PE, Lynch B, Kirov G, O'Riordan S, Samuel M, Lynch T, King MD, Chinnery PF, Warner TT, Blake DJ, Owen MJ, Morris HR.

J Neurol. 2014 Dec;261(12):2296-304. doi: 10.1007/s00415-014-7488-3. Epub 2014 Sep 11.

38.

Plasma melatonin is reduced in Huntington's disease.

Kalliolia E, Silajdžić E, Nambron R, Hill NR, Doshi A, Frost C, Watt H, Hindmarsh P, Björkqvist M, Warner TT.

Mov Disord. 2014 Oct;29(12):1511-5. doi: 10.1002/mds.26003. Epub 2014 Aug 27.

PMID:
25164424
39.

In a rush to decide: deep brain stimulation and dopamine agonist therapy in Parkinson's disease.

Djamshidian A, O'Sullivan SS, Tomassini A, Foltynie T, Limousin P, Aviles-Olmos I, Warner TT, Lees AJ, Averbeck BB.

J Parkinsons Dis. 2014;4(4):579-83. doi: 10.3233/JPD-140388.

40.

DRD1 rare variants associated with tardive-like dystonia: a pilot pathway sequencing study in dystonia.

Groen JL, Ritz K, Warner TT, Baas F, Tijssen MA.

Parkinsonism Relat Disord. 2014 Jul;20(7):782-5. doi: 10.1016/j.parkreldis.2014.04.002. Epub 2014 Apr 13.

PMID:
24768614
41.

Late onset ataxia: MSA-C or SCA 17? A gene penetrance dilemma.

Doherty KM, Warner TT, Lees AJ.

Mov Disord. 2014 Jan;29(1):36-8. doi: 10.1002/mds.25770. Epub 2013 Dec 16. No abstract available.

PMID:
24343983
42.

A systematic evaluation of integration free reprogramming methods for deriving clinically relevant patient specific induced pluripotent stem (iPS) cells.

Goh PA, Caxaria S, Casper C, Rosales C, Warner TT, Coffey PJ, Nathwani AC.

PLoS One. 2013 Nov 26;8(11):e81622. doi: 10.1371/journal.pone.0081622. eCollection 2013.

43.

Emerging common molecular pathways for primary dystonia.

Ledoux MS, Dauer WT, Warner TT.

Mov Disord. 2013 Jun 15;28(7):968-81. doi: 10.1002/mds.25547. Review.

44.

Dystonia rating scales: critique and recommendations.

Albanese A, Sorbo FD, Comella C, Jinnah HA, Mink JW, Post B, Vidailhet M, Volkmann J, Warner TT, Leentjens AF, Martinez-Martin P, Stebbins GT, Goetz CG, Schrag A.

Mov Disord. 2013 Jun 15;28(7):874-83. doi: 10.1002/mds.25579. Review.

45.

Recent advances in the molecular pathogenesis of dystonia-plus syndromes and heredodegenerative dystonias.

Casper C, Kalliolia E, Warner TT.

Curr Neuropharmacol. 2013 Jan;11(1):30-40. doi: 10.2174/157015913804999432.

46.

Perrault syndrome is caused by recessive mutations in CLPP, encoding a mitochondrial ATP-dependent chambered protease.

Jenkinson EM, Rehman AU, Walsh T, Clayton-Smith J, Lee K, Morell RJ, Drummond MC, Khan SN, Naeem MA, Rauf B, Billington N, Schultz JM, Urquhart JE, Lee MK, Berry A, Hanley NA, Mehta S, Cilliers D, Clayton PE, Kingston H, Smith MJ, Warner TT; University of Washington Center for Mendelian Genomics, Black GC, Trump D, Davis JR, Ahmad W, Leal SM, Riazuddin S, King MC, Friedman TB, Newman WG.

Am J Hum Genet. 2013 Apr 4;92(4):605-13. doi: 10.1016/j.ajhg.2013.02.013. Epub 2013 Mar 28.

47.

SGCE mutations cause psychiatric disorders: clinical and genetic characterization.

Peall KJ, Smith DJ, Kurian MA, Wardle M, Waite AJ, Hedderly T, Lin JP, Smith M, Whone A, Pall H, White C, Lux A, Jardine P, Bajaj N, Lynch B, Kirov G, O'Riordan S, Samuel M, Lynch T, King MD, Chinnery PF, Warner TT, Blake DJ, Owen MJ, Morris HR.

Brain. 2013 Jan;136(Pt 1):294-303. doi: 10.1093/brain/aws308.

48.

A critical evaluation of inflammatory markers in Huntington's Disease plasma.

Silajdžić E, Rezeli M, Végvári Á, Lahiri N, Andre R, Magnusson-Lind A, Nambron R, Kalliolia E, Marko-Varga G, Warner TT, Laurell T, Tabrizi SJ, Björkqvist M.

J Huntingtons Dis. 2013;2(1):125-34. doi: 10.3233/JHD-130049.

PMID:
25063434
49.

Paroxysmal exercise-induced dyskinesia of the hands.

Clark CN, Weber YW, Lerche H, Warner TT.

Mov Disord. 2012 Oct;27(12):1579-80. doi: 10.1002/mds.25200. Epub 2012 Oct 4. No abstract available.

PMID:
23037144
50.

What sample sizes for reliability and validity studies in neurology?

Hobart JC, Cano SJ, Warner TT, Thompson AJ.

J Neurol. 2012 Dec;259(12):2681-94. doi: 10.1007/s00415-012-6570-y. Epub 2012 Jun 24.

PMID:
22729386

Supplemental Content

Loading ...
Support Center